Entia Biosciences (ERGO) 10-Q 13 Nov 15 2015 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 13, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Entia Biosciences, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		29,103,587
Amendment Flag	false
Entity Central Index Key	1,408,299
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3

CONSOLIDATED BALANCE SHEETS (Un

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current Assets:
Cash	$ 41,354	$ 99,462
Accounts receivable, net	53,128	243,782
Inventory, net	117,784	95,376
Prepaid expenses	15,109	46,107
Total Current Assets	227,375	484,727
Property and Equipment, net	36,322	43,147
Patents and license, net	345,441	342,834
Total Assets	609,138	870,708
Current Liabilities:
Accounts payable and accrued expenses	761,907	569,169
Short-term convertible notes payable, net of discount related-party	14,440	9,399
Short-term convertible notes payable, net of discount	118,592	357,646
Notes payable	5,488	51,030
Total Current Liabilities	900,427	987,244
Total Liabilities	900,427	987,244
Stockholders' Equity (Deficit):
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Series A preferred stock, 350,000 shares designated, 191,307 and 200,807 shares issued and outstanding, respectively, aggregate liquidation value of $956,535 and $1,004,035 respectively	191	201
Common stock, $0.001 par value, 150,000,000 shares authorized, 29,103,587 and 15,512,927 shares issued and outstanding, respectively	29,104	15,514
Additional paid-in capital	12,516,104	10,771,035
Deferred compensation	(62,980)	(86,344)
Accumulated deficit	(12,773,708)	(10,816,942)
Total Stockholders' Equity (Deficit)	(291,289)	(116,536)
Total Liabilities and Stockholders' Equity (Deficit)	$ 609,138	$ 870,708

CONSOLIDATED BALANCE SHEETS (U3

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Common stock par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	29,103,587	15,512,927
Common stock, shares outstanding	29,103,587	15,512,927
Series A Preferred Stock [Member]
Preferred stock, shares authorized	350,000	350,000
Preferred stock, shares issued	191,307	200,807
Preferred stock, shares outstanding	191,307	200,807
Preferred stock, aggregate liquidation value (in Dollars)	$ 956,535	$ 1,004,035

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
REVENUES	$ 68,048	$ 87,753	$ 278,513	$ 355,014
COST OF GOODS SOLD	21,592	40,059	99,940	136,083
GROSS PROFIT	46,456	47,694	178,573	218,931
OPERATING EXPENSES
Advertising and promotion	26,752	42,368	104,986	77,454
Professional fees	90,766	36,166	190,777	123,382
Consulting fees	46,865	21,440	410,339	315,032
Impairment of intangible asset	0	27,080	0	27,080
General and administrative	215,864	334,358	1,217,445	1,051,506
Total Operating Expenses	380,247	461,412	1,923,547	1,594,454
LOSS FROM OPERATIONS	(333,791)	(413,718)	(1,744,974)	(1,375,523)
OTHER INCOME (EXPENSES)
Interest expense	(8,362)	(82,123)	(142,550)	(256,525)
Other income (expense)	(31,675)	37,499	(20,327)	24,534
Loss on write-off of debt discount	0	(100,000)	(23,321)	(100,000)
Loss on settlement of notes payable	0	0	(32,500)	0
Gain on settlement of accounts payable	6,906	0	6,906	103,021
NET LOSS	$ (366,922)	$ (558,342)	$ (1,956,766)	$ (1,604,493)
NET LOSS PER COMMON SHARE - BASIC AND DILUTED: (in Dollars per share)	$ (0.01)	$ (0.06)	$ (0.09)	$ (0.18)
Weighted common shares outstanding - basic and diluted (in Shares)	28,319,757	10,091,052	22,680,896	8,986,310

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - 9 months ended Sep. 30, 2015 - USD ($)	Preferred Stock [Member]Convertble Preferred Shares [Member]	Preferred Stock [Member]	Common Stock [Member]Convertble Preferred Shares [Member]	Common Stock [Member]Conversion of Convertible Debt [Member]	Common Stock [Member]Conversion of Accounts Payable [Member]	Common Stock [Member]Conversion of Warrants [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]Warrants Issued for Convertible Notes [Member]	Additional Paid-in Capital [Member]Convertble Preferred Shares [Member]	Additional Paid-in Capital [Member]Conversion of Convertible Debt [Member]	Additional Paid-in Capital [Member]Conversion of Accounts Payable [Member]	Additional Paid-in Capital [Member]Conversion of Warrants [Member]	Additional Paid-in Capital [Member]Warrants Issued for Services [Member]	Additional Paid-in Capital [Member]Warrants Issued for Sales Agreement [Member]	Additional Paid-in Capital [Member]	Deferred Compensation, Share-based Payments [Member]Warrants Issued for Services [Member]	Deferred Compensation, Share-based Payments [Member]	Stock Subscriptions [Member]	Retained Earnings [Member]Warrants Issued for Convertible Notes [Member]	Retained Earnings [Member]Conversion of Convertible Debt [Member]	Retained Earnings [Member]Conversion of Accounts Payable [Member]	Retained Earnings [Member]Warrants Issued for Sales Agreement [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2014		$ 201					$ 15,514								$ 10,771,035		$ (86,344)	$ (10,816,942)					$ (116,536)	$ (116,536)
Balance (in Shares) at Dec. 31, 2014		200,807					15,512,927
Issuance of warrants								$ 6,850					$ 36,597	$ 7,891		$ (36,597)			$ 6,850			$ 7,891
Amortization of deferred compensation																	91,253						91,253
Net loss																		(1,956,766)					(1,956,766)	(1,956,766)
Issuance of common stock for cash							$ 5,348								554,825								560,173
Issuance of common stock for cash (in Shares)							5,347,901
Issuance of common stock for conversion of securities	$ (10)		$ 95	$ 3,069	$ 554	$ 2,051			$ (85)	$ 318,632	$ 130,054	$ (2,051)								$ 321,701	$ 130,608
Issuance of common stock for conversion of securities (in Shares)	(9,500)		95,000	3,068,882	554,521	2,050,923
Stock compensation							$ 1,550								541,782								543,332
Stock compensation (in Shares)							1,550,000
Issuance of common stock for services							$ 923								119,282								120,205
Issuance of common stock for services (in Shares)							923,433
Balance at Sep. 30, 2015		$ 191					$ 29,104								$ 12,516,104		$ (62,980)	$ (12,773,708)					$ (291,289)	$ (291,289)
Balance (in Shares) at Sep. 30, 2015		191,307					29,103,587

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,956,766)	$ (1,604,493)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation/amortization	24,989	56,318
Gain on settlement of accounts payable	(6,906)	(103,021)
Impairment of intangible asset	0	27,080
Loss on write-off of debt discount	23,321	100,000
Amortization of discount on convertible notes	111,837	221,548
Loss on conversion of notes payable	32,500	0
Stock-based compensation	762,681	486,568
Loss on sale of stock subscription receivable	0	12,965
Changes in operating assets and liabilities:
Accounts receivable	190,654	(54,465)
Inventory	(22,408)	22,163
Prepaid expenses	39,334	28,275
Accounts payable and accrued expenses	323,632	404,761
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	(477,132)	(402,301)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(8,051)	(4,607)
Acquisition of patents and patents pending (net)	(12,720)	(28,328)
NET CASH USED IN INVESTING ACTIVITIES	(20,771)	(32,935)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	560,173	0
Proceeds from convertible notes payable and notes payable	50,000	503,000
Payment on notes payable	(170,378)	(34,042)
Payment on convertible note payable - related party	0	(40,000)
Proceeds from sale of stock subscription receivable	0	40,000
Proceeds from convertible note payable-related party	0	15,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	439,795	483,958
NET CHANGE IN CASH	(58,108)	48,722
Cash at beginning of period	99,462	36,886
Cash at end of period	41,354	85,608
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid	36,220	843
SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING AND INVESTING ACTIVITIES:
Issuance of warrants for accrued salary	0	91,863
Covnersion of Convertible Notes Payable and Acrrued Interest [Member]
SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING AND INVESTING ACTIVITIES:
Stock Issued	452,309	1,087,490
Stock Issued for Services Rendered [Member]
SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING AND INVESTING ACTIVITIES:
Stock Issued	$ 120,205	$ 39,556

NOTE 1 - ORGANIZATION AND OPERA

NOTE 1 - ORGANIZATION AND OPERATIONS	9 Months Ended
	Sep. 30, 2015
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 – ORGANIZATION AND OPERATIONS We have a history of incurring net losses and net operating cash flow deficits. At September 30, 2015, we had cash and cash equivalents of $41,354. We will require additional capital of at least approximately $135,000 to repay debt principal and accrued interest maturing during fourth quarter 2015 and we intend to raise the monies by undertaking one or more equity-based private placements. In addition, of this $135,000, $60,000 in notes payable is now due and its conversion into our common stock is under discussion with the holder. We are confident this note will be converted or otherwise settled prior to the end of our fiscal year. These conditions raise substantial doubt about our ability to continue as a going concern. However, we anticipate that our anticipated cash flows from operations and from on-going financing activities will be sufficient to meet our cash requirements through December 2015.

NOTE 2 - SUMMARY OF SIGNIFICANT

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation and principles of consolidation Use of estimates Cash Accounts receivable Inventory Property and equipment Office equipment 3 years Production equipment 5 to 7 years Equipment under capital lease 5 to 7 years Leasehold improvements Lesser of lease term or useful life of improvement Patents Impairment of long-lived assets Discount on convertible notes payable Fair value of financial instruments Fair value measurements Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Unobservable inputs where there is little or no market data, which require the reporting entity to develop its own assumptions. We do not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis. Consequently, we did not have any fair value adjustments for assets and liabilities measured at fair value at September 30, 2015 or December 31, 2014, nor any gains or losses reported in the consolidated statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the periods ended September 30, 2015 and September 30, 2014. Revenue recognition We recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been performed, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured. Shipping and handling costs Advertising and promotion costs Equity instruments issued to parties other than employees for acquiring goods or services The assumptions used to determine the fair value of our warrants are as follows: - The expected life of warrants issued represents the period of time the warrants are expected to be outstanding. - The expected volatility is generally based on the historical volatility of comparable companies’ stock over the contractual life of the warrant. - The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the warrant. - The expected dividend yield is based on our current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the warrant. Income taxes Net loss per common share For the Three Months Ended September 30, For the Nine Months Ended September 30, 2015 2014 2015 2014 Numerator: Net loss $ (366,922 ) $ (558,342 ) $ (1,956,766 ) $ (1,604,493 ) Denominator: Weighted-average common shares outstanding 28,319,757 10,091,052 22,680,896 8,986,310 Basic and diluted net loss per share $ (0.01 ) $ (0.06 ) $ (0.09 ) $ (0.18 ) Common stock warrants 19,091,578 5,019,006 19,091,578 5,019,006 Series A convertible preferred stock 1,913,070 2,078,070 1,913,070 2,078,070 Stock options 2,896,470 2,848,670 2,896,470 2,848,670 Convertible debt including interest 96,013 915,085 96,013 915,085 Excluded dilutive securities 23,997,131 10,860,831 23,997,131 10,860,831 Reclassifications Segments Recently issued accounting pronouncements

NOTE 3 - INVENTORY

NOTE 3 - INVENTORY	9 Months Ended
	Sep. 30, 2015
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	NOTE 3 – INVENTORY Inventory consists of the following at: September 30, 2015 December 31, 2014 Raw materials $ 34,903 $ 202,591 Finished goods 233,945 43,849 268,848 246,440 Less: reserve for excess and obsolete inventory (151,064 ) (151,064 ) $ 117,784 $ 95,376

NOTE 4 - PROPERTY AND EQUIPMENT

NOTE 4 - PROPERTY AND EQUIPMENT	9 Months Ended
	Sep. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 4 – PROPERTY AND EQUIPMENT September 30, 2015 December 31, 2014 Office equipment $ 31,658 $ 27,507 Production equipment 90,899 86,999 Leasehold improvements 16,328 16,328 138,885 130,834 Less: accumulated depreciation (102,563 ) (87,687 ) $ 36,322 $ 43,147

NOTE 5 - PATENTS AND LICENSES,

NOTE 5 - PATENTS AND LICENSES, NET	9 Months Ended
	Sep. 30, 2015
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	NOTE 5 – PATENTS AND LICENSES, NET September 30, 2015 December 31, 2014 Licenses and amortizable patents $ 207,244 $ 207,244 Unamortized patents 178,878 166,159 Accumulated amortization (40,681 ) (30,569 ) Patents and Licenses, net $ 345,441 $ 342,834

NOTE 6 - ACCRUED EXPENSES

NOTE 6 - ACCRUED EXPENSES	9 Months Ended
	Sep. 30, 2015
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE 6 – ACCRUED EXPENSES Accrued expenses (included with accounts payable) consists of the following at: September 30, 2015 December 31, 2014 Executive compensation $ 327,285 $ 153,432 Other accruals 27,372 19,725 $ 354,657 $ 173,157

NOTE 7 - NOTES PAYABLE

NOTE 7 - NOTES PAYABLE	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 7 – NOTES PAYABLE Notes payable consists of the following: September 30, 2015 December 31, 2014 Notes payable - current 7.85% unsecured, $473 due monthly $ - $ 2,304 5.86% unsecured, $545 due monthly 4,268 - 7.85% unsecured, $314 due monthly 1,220 - 4.15% unsecured, $3,436 due monthly - 23,726 10.00% unsecured, interest only, due on demand. Note was settled on May 29, 2015 in exchange for 250,000 shares of common stock. In addition, 500,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. We calculated and posted a loss on the settlement in the amount of $32,500. - 25,000 $ 5,488 $ 51,030 Convertible notes payable, net 8% secured due on December 26, 2015 (net of discount related to beneficial conversion feature of $1,408 in 2015 and $7,746 in 2014), convertible into preferred stock at $5.00 per share. $ 48,592 $ 42,254 6% unsecured, convertible into common stock at $2.00 per share, due on demand 50,000 50,000 10% unsecured due March 2015 (net of discount related to warrants of $0 in 2015 and $2,362 in 2014). Note and accrued interest were converted on May 7, 2015 for 275,000 shares of common stock. In addition, 550,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 22,638 10% unsecured due April 2015 (net of discount related to warrants of $0 in 2015 and $9,800 in 2014). Note and accrued interest were converted on April 30, 2015 for 1,100,000 shares of common stock. In addition, 2,200,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 90,200 10% unsecured due April 2015 (net of discount related to warrants of $0 in 2015 and $1,377 in 2014). Paid in full in April 2015. - 8,623 8% unsecured due April 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $11,968 in 2014), This note was converted into 527,911 shares of common stock during first quarter 2015 - 30,532 8% unsecured due May 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $19,190 in 2014), $25,000 of this note was converted into 318,471 shares of common stock while the remaining $28,000 was repaid in cash during first quarter 2015. - 33,810 10% unsecured due December 2015 (net of discount related to warrants of $0 and $4,620 in 2014). This note was converted in July 2015 for 322,500 shares of common stock In addition, 645,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 25,380 10% unsecured due December 2015 (net of discount related to warrants of $0 in 2015 and $1,727 in 2014) convertible price to be determined by the purchase price paid by investors in future offerings, not to exceed $1.50 per share 10,000 8,273 10% unsecured due October 2015 (net of discount related to warrants of $0 in 2015 and $1,805 in 2014) convertible price to be determined by the purchase price paid by investors in future offerings, not to exceed $1.50 per share. We are currently in contract extension negotiations. 10,000 8,195 10% unsecured due October 2015 (net of discount related to warrants of $0 in 2015 and $4,512 in 2014) Note and accrued interest were converted on May 21, 2015 for 275,000 shares of common stock. In addition, 550,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 20,488 8% unsecured due September 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $36,247 in 2014). This note was paid off in Q2. - 17,253 $ 118,592 $ 357,646 Convertible notes payable, net related party 0% unsecured due November 2015 (net of discount related to beneficial conversion feature of $274 in 2015 and $2,738 in 2014 and net of discount related to warrants of $286 in 2015 and $2,863 in 2014 and convertible into common stock at $0.30 per share.) $ 14,440 $ 9,399 $ 14,440 $ 9,399

NOTE 8 - RELATED PARTY TRANSACT

NOTE 8 - RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 8 – RELATED PARTY TRANSACTIONS Common stock issued On April 17, 2015, the board of directors authorized and granted to its executives and board of directors for the year end 2015, restricted common stock bonuses as follows: o Marvin Hausman, CEO, 600,000 shares valued at $120,000, o Devin Andres, COO, 550,000 shares valued at $110,000, o Philip Sobol, board of directors, 200,000 shares valued at $40,000, and o Elliott Shelton, board of directors, 200,000 shares valued at $40,000. Debt agreements from board member

NOTE 9 - STOCKHOLDERS' EQUITY (

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT)	9 Months Ended
	Sep. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 9 – STOCKHOLDERS’ EQUITY (DEFICIT) Preferred Stock On May 26, 2011, our board of directors designated 350,000 shares of our authorized preferred stock as Series A preferred stock, $0.001 par value per share. The Series A preferred stock is entitled to a liquidation preference, votes on an as-converted basis with our common stock on all matters as to which holders of common stock are entitled to vote, and is convertible into common stock on a one-for-ten basis. In September 2015, our new executive management became aware that the 2011 designation of the Series A preferred stock by our board of directors was not authorized by the Company’s Articles of Incorporation. As a result, the shares of Series A preferred stock issued by the Company were not duly authorized and, further, uncertainty exists as to the validity of the subsequent conversion by certain holders of Series A preferred stock of some of these shares into common stock. On October 1, 2015, Nevada’s corporations statute was amended by means of Nevada Senate Bill No. 446 so as to allow retroactive correction of the aforementioned authorization issue through a ratification vote or consent of our shareholders (which excludes the vote or consent as to any shares of Series A preferred stock or any shares of common stock issued upon conversion of the Series A preferred stock). We are undertaking to receive such ratification through a written consent solicitation of our shareholders. We believe that we will be successful in obtaining this ratification, at which point all outstanding shares of our Series A preferred stock and, as the case may be, the common stock into which any of our Series A preferred stock has been converted will be validly issued and outstanding. Common stock o 15,000 shares of common stock for conversion of 1,500 shares of Series A preferred stock, o 418,750 shares of common stock with a value of $82,838 for services rendered, o 193,856 shares of common stock in exchange for conversion of accounts payable in the amount of $22,776, o 322,500 shares of common stock in exchange for conversion of notes payable in the amount of $30,000 plus accrued interest of $2,250, o 567,901 shares of common stock for $40,168 cash, and o 111,683 shares of common stock with a value of $14,072 in payment of accrued payroll. o 80,000 shares of common stock for conversion of 8,000 shares of Series A preferred stock, o 4,350,000 shares of common stock issued for $435,000 in cash, o 1,550,000 shares of common stock issued to the board of directors and executives valued at $310,000, o 1,900,000 shares of common stock in exchange for conversion of notes payable in the amount of $175,000 plus accrued interest of $12,500, o 2,050,923 shares of common stock in a cashless exchange for 2,158,867 warrants, o 305,165 shares of common stock with a value of $96,732 in exchange for conversion of accounts payable, and o 365,000 shares of common stock with a value of $78,913 for services rendered. o 28,000 shares of common stock for a value of $10,383 for services rendered, o 430,000 shares of common stock issued for $85,005 in cash, o 846,382 shares of common stock in exchange for conversion of notes payable in the amount of $67,500 plus accrued interest of $1,720, and o 55,500 shares with a value of $11,100 in exchange for conversion of accounts payable. o 645,885 shares of common stock with a value of $77,200 upon conversion of $75,500 of convertible notes payable along with accrued interest of $1,700, o 300,000 shares of common stock for conversion of 30,000 shares of Series A preferred stock, o 2,592,570 shares of common stock in exchange for converting $777,770 of accrued salary to two key employees, o 400,000 shares of common stock with a value of $107,882 in exchange for conversion of notes payable, o 7,813 shares of common stock with a value of $5,000 for the conversion of accounts payable, o 50,000 shares of common stock in conjunction with a distributor agreement value at $21,500. This amount is posted as a reduction in revenues, and o 75,000 shares of common stock with a value of $33,713 for services rendered. o 151,126 shares of common stock with a value of $32,520 upon conversion of $30,000 of convertible notes payable along with accrued interest of $2,520, o 23,000 shares of common stock with a value of $13,113 for services rendered, o 441,620 shares of common stock in exchange for 44,162 shares of Series A preferred stock, and o 80,000 shares of common stock with a value of $46,400 for the settlement of accounts payable in the amount of $149,421. We posted a gain on settlement in the amount of $103,021. o 64,700 shares of common stock for a value of $39,556 for services rendered, o 79,293 shares of common stock for a value of $44,250 for services to be performed in the future, and o 6,717 shares of common stock with a value of $4,501 for the settlement of accounts payable. Stock incentive plan A summary of option activity under the stock option plan as of September 30, 2015 and changes during the nine months then ended is presented below: Weighted Weighted Average Average Remaining Aggregate Number of Exercise Price Exercise Contractual Term Intrinsic Shares Range Price (Years) Value Outstanding, December 31, 2013 2,352,099 $ 0.38 - $1.00 $ 0.51 7.90 199,505 Exercisable, December 31, 2013 1,810,344 $ 0.38 - $1.00 $ 0.52 7.88 138,707 Granted 624,571 $ 0.40 - $0.75 $ 0.52 6.49 - Exercised - - $ - - - Expired/Forfeited 110,200 $ 0.40 - $0.50 $ 0.48 9.51 - Outstanding, December 31, 2014 2,866,470 $ 0.30 - $1.00 $ 0.48 8.96 - Exercisable, December 31, 2014 2,321,001 $ 0.38 - $1.00 $ 0.47 9.50 - Granted 30,000 $ 0.20 $ 0.20 5.00 - Exercised - - $ - - - Expired/Forfeited - - $ - - - Outstanding, September 30, 2015 2,896,470 $ .0.20 - $1.00 $ 0.46 11.24 - Exercisable, September 30, 2015 2,652,799 $ 0.20 - $1.00 $ 0.45 11.66 - Number of Exercise shares Price 190,000 $ 0.20 300,000 $ 0.30 55,000 $ 0.38 1,186,670 $ 0.40 10,000 $ 0.45 631,800 $ 0.50 160,000 $ 0.60 15,000 $ 0.62 100,000 $ 0.75 10,000 $ 0.81 200,000 $ 0.85 38,000 $ 1.00 2,896,470 At September 30, 2015, the Company had 1,803,530 unissued shares available under the Plan. Also, at September 30, 2015, the Company had $119,011 of total unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 11 years. Warrants – Consulting Agreements Date of Issue September 30, 2015 Exercise Price Expiration July-15 1,445,000 $ 0.125 - $0.15 07/2018 June-15 302,500 $ 0.125 - $0.15 06/2018 May-15 6,160,000 $ 0.125 - $0.23 05/2018 - 05/2022 April-15 6,160,000 $ 0.01 - $0.15 04/2018 - 04/2027 March-15 140,000 $ 0.10 - $0.75 03/2018 - 03/2022 February-15 - $ 0.00 - January-15 70,000 $ 0.30 - $0.50 01/2020 As of December 2014 7,271,454 $ 0.36 - $10.00 05/2015 - 10/2024 Total 21,548,954 Less: Expired 298,509 Exercised 2,158,867 Total 19,091,578 We use the Black-Scholes option-pricing model to determine the fair value of warrants on the date of grant. In determining the fair value of warrants, we employed the following key assumptions: September 30, 2015 December 31, 2014 Risk-Free interest rate 0.28% - 1.72 % 0.28% - 2.97 % Expected dividend yield 0 % 0 % Volatility 166.10% - 204.66 % 182.81% - 222.30 % Expected life 3 - 7 years 3-10 years $ 0.14 $ 0.39 At September 30, 2015 and December 31, 2014, the weighted-average Black-Scholes value of warrants granted was $0.14 and $0.39, respectively. On May 20 2015, the board of directors agreed to extend the warrants and options of all employees and the board of directors by 5 years from original date and to reduce the exercise price to $0.40, if favorable to holder. We calculated a loss on modification of the warrants and options of $56,543 and have posted this expense during the second quarter. In addition, on May 20, 2015, the Company agreed to extend the outstanding options of a consultant for 5 years and reduce their exercise price to $0.20. We have calculated a loss on the modification in the amount of $4,524 and have posted this expense during the second quarter.

NOTE 10 - COMMITMENTS AND CONTI

NOTE 10 - COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 10 – COMMITMENTS AND CONTINGENCIES Leases On April 4, 2012, the Company entered into a Commercial Lease agreement with Lanz Properties, LLC for 13,081 square feet of office and warehouse space located at 13565 SW Tualatin-Sherwood Road, Suite 800, Sherwood, OR 97140. The new lease commenced on June 1, 2012 and terminated on July 31, 2015. No rent was payable until October 2012. The base monthly rental rate started at $3,160, increasing to $3,260 in October 2013, and then $3,343 in June 2014. The Company has straight-lined the full value of the lease agreement over the life of the lease and has recorded this amount monthly. The amount of rent expense that is above the actual rent amount is recorded as deferred rent and is shown on the balance sheet in current liabilities as part of accounts payable and accrued expenses. The amount recorded for as of September 30, 2015 and 2014 is $0 and $5,406, respectively. On May 8, 2015, the Company entered into a lease addendum with Lanz Properties, LLC to extend their lease term for an additional 3 years. The new lease terms maintain the current base monthly rental rate from August 1, 2015 of $3,343 per month increasing to $3,410 in August 2016 and then $3,478 in August 2017. All other provisions of the lease remain. The Company has analyzed the requirement to straight-line the full value of the lease agreement over the life of the lease and has determined that there is no need to book a deferred rent amount on the balance sheet as the amount is immaterial.

NOTE 11 - SUBSEQUENT EVENTS

NOTE 11 - SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 11 – SUBSEQUENT EVENTS

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of presentation and principles of consolidation
Use of Estimates, Policy [Policy Text Block]	Use of estimates
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash
Receivables, Policy [Policy Text Block]	Accounts receivable
Inventory, Policy [Policy Text Block]	Inventory
Property, Plant and Equipment, Policy [Policy Text Block]	Property and equipment Office equipment 3 years Production equipment 5 to 7 years Equipment under capital lease 5 to 7 years Leasehold improvements Lesser of lease term or useful life of improvement
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Patents
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of long-lived assets
Debt, Policy [Policy Text Block]	Discount on convertible notes payable
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair value of financial instruments
Fair Value Measurement, Policy [Policy Text Block]	Fair value measurements Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Unobservable inputs where there is little or no market data, which require the reporting entity to develop its own assumptions. We do not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis. Consequently, we did not have any fair value adjustments for assets and liabilities measured at fair value at September 30, 2015 or December 31, 2014, nor any gains or losses reported in the consolidated statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the periods ended September 30, 2015 and September 30, 2014.
Revenue Recognition, Policy [Policy Text Block]	Revenue recognition We recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been performed, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping and handling costs
Advertising Costs, Policy [Policy Text Block]	Advertising and promotion costs
Stockholders' Equity, Policy [Policy Text Block]	Equity instruments issued to parties other than employees for acquiring goods or services The assumptions used to determine the fair value of our warrants are as follows: - The expected life of warrants issued represents the period of time the warrants are expected to be outstanding. - The expected volatility is generally based on the historical volatility of comparable companies’ stock over the contractual life of the warrant. - The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the warrant. - The expected dividend yield is based on our current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the warrant.
Income Tax, Policy [Policy Text Block]	Income taxes
Earnings Per Share, Policy [Policy Text Block]	Net loss per common share For the Three Months Ended September 30, For the Nine Months Ended September 30, 2015 2014 2015 2014 Numerator: Net loss $ (366,922 ) $ (558,342 ) $ (1,956,766 ) $ (1,604,493 ) Denominator: Weighted-average common shares outstanding 28,319,757 10,091,052 22,680,896 8,986,310 Basic and diluted net loss per share $ (0.01 ) $ (0.06 ) $ (0.09 ) $ (0.18 ) Common stock warrants 19,091,578 5,019,006 19,091,578 5,019,006 Series A convertible preferred stock 1,913,070 2,078,070 1,913,070 2,078,070 Stock options 2,896,470 2,848,670 2,896,470 2,848,670 Convertible debt including interest 96,013 915,085 96,013 915,085 Excluded dilutive securities 23,997,131 10,860,831 23,997,131 10,860,831
Reclassification, Policy [Policy Text Block]	Reclassifications
Segment Reporting, Policy [Policy Text Block]	Segments
New Accounting Pronouncements, Policy [Policy Text Block]	Recently issued accounting pronouncements

NOTE 2 - SUMMARY OF SIGNIFICA19

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2015
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) [Line Items]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table presents a reconciliation of basic loss per share and excluded dilutive securities: For the Three Months Ended September 30, For the Nine Months Ended September 30, 2015 2014 2015 2014 Numerator: Net loss $ (366,922 ) $ (558,342 ) $ (1,956,766 ) $ (1,604,493 ) Denominator: Weighted-average common shares outstanding 28,319,757 10,091,052 22,680,896 8,986,310 Basic and diluted net loss per share $ (0.01 ) $ (0.06 ) $ (0.09 ) $ (0.18 ) Common stock warrants 19,091,578 5,019,006 19,091,578 5,019,006 Series A convertible preferred stock 1,913,070 2,078,070 1,913,070 2,078,070 Stock options 2,896,470 2,848,670 2,896,470 2,848,670 Convertible debt including interest 96,013 915,085 96,013 915,085 Excluded dilutive securities 23,997,131 10,860,831 23,997,131 10,860,831
Estimated Useful Lives [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) [Line Items]
Property, Plant and Equipment [Table Text Block]	Depreciation is computed on a straight-line basis over the following estimated useful lives of the assets: Office equipment 3 years Production equipment 5 to 7 years Equipment under capital lease 5 to 7 years Leasehold improvements Lesser of lease term or useful life of improvement

NOTE 3 - INVENTORY (Tables)

NOTE 3 - INVENTORY (Tables)	9 Months Ended
	Sep. 30, 2015
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventory consists of the following at: September 30, 2015 December 31, 2014 Raw materials $ 34,903 $ 202,591 Finished goods 233,945 43,849 268,848 246,440 Less: reserve for excess and obsolete inventory (151,064 ) (151,064 ) $ 117,784 $ 95,376

NOTE 4 - PROPERTY AND EQUIPME21

NOTE 4 - PROPERTY AND EQUIPMENT (Tables)	9 Months Ended
	Sep. 30, 2015
Property, Plant and Equipment Table [Member]
NOTE 4 - PROPERTY AND EQUIPMENT (Tables) [Line Items]
Property, Plant and Equipment [Table Text Block]	Property and equipment, stated at cost, consists of the following at: September 30, 2015 December 31, 2014 Office equipment $ 31,658 $ 27,507 Production equipment 90,899 86,999 Leasehold improvements 16,328 16,328 138,885 130,834 Less: accumulated depreciation (102,563 ) (87,687 ) $ 36,322 $ 43,147

NOTE 5 - PATENTS AND LICENSES22

NOTE 5 - PATENTS AND LICENSES, NET (Tables)	9 Months Ended
	Sep. 30, 2015
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	The gross carrying amounts and accumulated amortization related to these intangible assets consist of the following at: September 30, 2015 December 31, 2014 Licenses and amortizable patents $ 207,244 $ 207,244 Unamortized patents 178,878 166,159 Accumulated amortization (40,681 ) (30,569 ) Patents and Licenses, net $ 345,441 $ 342,834

NOTE 6 - ACCRUED EXPENSES (Tabl

NOTE 6 - ACCRUED EXPENSES (Tables)	9 Months Ended
	Sep. 30, 2015
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	Accrued expenses (included with accounts payable) consists of the following at: September 30, 2015 December 31, 2014 Executive compensation $ 327,285 $ 153,432 Other accruals 27,372 19,725 $ 354,657 $ 173,157

NOTE 7 - NOTES PAYABLE (Tables)

NOTE 7 - NOTES PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	Notes payable consists of the following: September 30, 2015 December 31, 2014 Notes payable - current 7.85% unsecured, $473 due monthly $ - $ 2,304 5.86% unsecured, $545 due monthly 4,268 - 7.85% unsecured, $314 due monthly 1,220 - 4.15% unsecured, $3,436 due monthly - 23,726 10.00% unsecured, interest only, due on demand. Note was settled on May 29, 2015 in exchange for 250,000 shares of common stock. In addition, 500,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. We calculated and posted a loss on the settlement in the amount of $32,500. - 25,000 $ 5,488 $ 51,030
Convertible Debt [Table Text Block]	Convertible notes payable, net 8% secured due on December 26, 2015 (net of discount related to beneficial conversion feature of $1,408 in 2015 and $7,746 in 2014), convertible into preferred stock at $5.00 per share. $ 48,592 $ 42,254 6% unsecured, convertible into common stock at $2.00 per share, due on demand 50,000 50,000 10% unsecured due March 2015 (net of discount related to warrants of $0 in 2015 and $2,362 in 2014). Note and accrued interest were converted on May 7, 2015 for 275,000 shares of common stock. In addition, 550,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 22,638 10% unsecured due April 2015 (net of discount related to warrants of $0 in 2015 and $9,800 in 2014). Note and accrued interest were converted on April 30, 2015 for 1,100,000 shares of common stock. In addition, 2,200,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 90,200 10% unsecured due April 2015 (net of discount related to warrants of $0 in 2015 and $1,377 in 2014). Paid in full in April 2015. - 8,623 8% unsecured due April 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $11,968 in 2014), This note was converted into 527,911 shares of common stock during first quarter 2015 - 30,532 8% unsecured due May 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $19,190 in 2014), $25,000 of this note was converted into 318,471 shares of common stock while the remaining $28,000 was repaid in cash during first quarter 2015. - 33,810 10% unsecured due December 2015 (net of discount related to warrants of $0 and $4,620 in 2014). This note was converted in July 2015 for 322,500 shares of common stock In addition, 645,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 25,380 10% unsecured due December 2015 (net of discount related to warrants of $0 in 2015 and $1,727 in 2014) convertible price to be determined by the purchase price paid by investors in future offerings, not to exceed $1.50 per share 10,000 8,273 10% unsecured due October 2015 (net of discount related to warrants of $0 in 2015 and $1,805 in 2014) convertible price to be determined by the purchase price paid by investors in future offerings, not to exceed $1.50 per share. We are currently in contract extension negotiations. 10,000 8,195 10% unsecured due October 2015 (net of discount related to warrants of $0 in 2015 and $4,512 in 2014) Note and accrued interest were converted on May 21, 2015 for 275,000 shares of common stock. In addition, 550,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 20,488 8% unsecured due September 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $36,247 in 2014). This note was paid off in Q2. - 17,253 $ 118,592 $ 357,646 Convertible notes payable, net related party 0% unsecured due November 2015 (net of discount related to beneficial conversion feature of $274 in 2015 and $2,738 in 2014 and net of discount related to warrants of $286 in 2015 and $2,863 in 2014 and convertible into common stock at $0.30 per share.) $ 14,440 $ 9,399 $ 14,440 $ 9,399

NOTE 9 - STOCKHOLDERS' EQUITY25

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Tables)	9 Months Ended
	Sep. 30, 2015
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of option activity under the stock option plan as of September 30, 2015 and changes during the nine months then ended is presented below: Weighted Weighted Average Average Remaining Aggregate Number of Exercise Price Exercise Contractual Term Intrinsic Shares Range Price (Years) Value Outstanding, December 31, 2013 2,352,099 $ 0.38 - $1.00 $ 0.51 7.90 199,505 Exercisable, December 31, 2013 1,810,344 $ 0.38 - $1.00 $ 0.52 7.88 138,707 Granted 624,571 $ 0.40 - $0.75 $ 0.52 6.49 - Exercised - - $ - - - Expired/Forfeited 110,200 $ 0.40 - $0.50 $ 0.48 9.51 - Outstanding, December 31, 2014 2,866,470 $ 0.30 - $1.00 $ 0.48 8.96 - Exercisable, December 31, 2014 2,321,001 $ 0.38 - $1.00 $ 0.47 9.50 - Granted 30,000 $ 0.20 $ 0.20 5.00 - Exercised - - $ - - - Expired/Forfeited - - $ - - - Outstanding, September 30, 2015 2,896,470 $ .0.20 - $1.00 $ 0.46 11.24 - Exercisable, September 30, 2015 2,652,799 $ 0.20 - $1.00 $ 0.45 11.66 -
Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Table Text Block]	The range of exercise prices for options outstanding under the 2010 Stock Incentive Plan at September 30, 2015 are as follows: Number of Exercise shares Price 190,000 $ 0.20 300,000 $ 0.30 55,000 $ 0.38 1,186,670 $ 0.40 10,000 $ 0.45 631,800 $ 0.50 160,000 $ 0.60 15,000 $ 0.62 100,000 $ 0.75 10,000 $ 0.81 200,000 $ 0.85 38,000 $ 1.00 2,896,470
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Outstanding warrants to purchase common stock are as follows: Date of Issue September 30, 2015 Exercise Price Expiration July-15 1,445,000 $ 0.125 - $0.15 07/2018 June-15 302,500 $ 0.125 - $0.15 06/2018 May-15 6,160,000 $ 0.125 - $0.23 05/2018 - 05/2022 April-15 6,160,000 $ 0.01 - $0.15 04/2018 - 04/2027 March-15 140,000 $ 0.10 - $0.75 03/2018 - 03/2022 February-15 - $ 0.00 - January-15 70,000 $ 0.30 - $0.50 01/2020 As of December 2014 7,271,454 $ 0.36 - $10.00 05/2015 - 10/2024 Total 21,548,954 Less: Expired 298,509 Exercised 2,158,867 Total 19,091,578
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	We use the Black-Scholes option-pricing model to determine the fair value of warrants on the date of grant. In determining the fair value of warrants, we employed the following key assumptions: September 30, 2015 December 31, 2014 Risk-Free interest rate 0.28% - 1.72 % 0.28% - 2.97 % Expected dividend yield 0 % 0 % Volatility 166.10% - 204.66 % 182.81% - 222.30 % Expected life 3 - 7 years 3-10 years $ 0.14 $ 0.39

NOTE 1 - ORGANIZATION AND OPE26

NOTE 1 - ORGANIZATION AND OPERATIONS (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013
NOTE 1 - ORGANIZATION AND OPERATIONS (Details) [Line Items]
Cash and Cash Equivalents, at Carrying Value	$ 41,354	$ 99,462	$ 85,608	$ 36,886
Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year	135,000
Convertible Notes Payable, Current	118,592	$ 357,646
Notes Now Due and Conversion Into Common Stock is Under Discussion [Member]
NOTE 1 - ORGANIZATION AND OPERATIONS (Details) [Line Items]
Convertible Notes Payable, Current	$ 60,000

NOTE 2 - SUMMARY OF SIGNIFICA27

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	9 Months Ended
	Sep. 30, 2015USD ($)	Dec. 31, 2014USD ($)
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Allowance for Doubtful Accounts Receivable (in Dollars)	$ 5,736	$ 30,022
Number of Operating Segments	1
Domestic Patents [Member] | Minimum [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	15 years
Domestic Patents [Member] | Maximum [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years
Foreign Patents [Member] | Minimum [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Foreign Patents [Member] | Maximum [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years

NOTE 2 - SUMMARY OF SIGNIFICA28

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Property, Plant and Equipment, Estimated Useful Lives	9 Months Ended
	Sep. 30, 2015
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Leasehold improvements	Lesser of lease term or useful life of improvement
Minimum [Member] | Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Minimum [Member] | Assets Held under Capital Leases [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Maximum [Member] | Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	7 years
Maximum [Member] | Assets Held under Capital Leases [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	7 years

NOTE 2 - SUMMARY OF SIGNIFICA29

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Earnings Per Share, Basic and Diluted - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Numerator:
Net loss (in Dollars)	$ (366,922)	$ (558,342)	$ (1,956,766)	$ (1,604,493)
Denominator:
Weighted-average common shares outstanding	28,319,757	10,091,052	22,680,896	8,986,310
Basic and diluted net loss per share (in Dollars per share)	$ (0.01)	$ (0.06)	$ (0.09)	$ (0.18)
Excluded dilutive securties	23,997,131	10,860,831	23,997,131	10,860,831
Warrant [Member]
Denominator:
Excluded dilutive securties	19,091,578	5,019,006	19,091,578	5,019,006
Convertble Preferred Shares [Member]
Denominator:
Excluded dilutive securties	1,913,070	2,078,070	1,913,070	2,078,070
Equity Option [Member]
Denominator:
Excluded dilutive securties	2,896,470	2,848,670	2,896,470	2,848,670
Convertible Debt Securities [Member]
Denominator:
Excluded dilutive securties	96,013	915,085	96,013	915,085

NOTE 3 - INVENTORY (Details) -

NOTE 3 - INVENTORY (Details) - Schedule of Inventory - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Schedule of Inventory [Abstract]
Raw materials	$ 34,903	$ 202,591
Finished goods	233,945	43,849
	268,848	246,440
Less: reserve for excess and obsolete inventory	(151,064)	(151,064)
	$ 117,784	$ 95,376

NOTE 4 - PROPERTY AND EQUIPME31

NOTE 4 - PROPERTY AND EQUIPMENT (Details) - Schedule of Property, Plant and Equipment - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 138,885	$ 130,834
Less: accumulated depreciation	(102,563)	(87,687)
	36,322	43,147
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	31,658	27,507
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	90,899	86,999
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 16,328	$ 16,328

NOTE 5 - PATENTS AND LICENSES32

NOTE 5 - PATENTS AND LICENSES, NET (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
NOTE 5 - PATENTS AND LICENSES, NET (Details) [Line Items]
Amortization of Intangible Assets	$ 3,372	$ 3,371	$ 10,112	$ 11,071
Licensing Agreements [Member]
NOTE 5 - PATENTS AND LICENSES, NET (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life			17 years
Licensing Agreements [Member] | Maximum [Member]
NOTE 5 - PATENTS AND LICENSES, NET (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life					17 years

NOTE 5 - PATENTS AND LICENSES33

NOTE 5 - PATENTS AND LICENSES, NET (Details) - Schedule of Finite-Lived Intangible Assets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	$ (40,681)	$ (30,569)
Patents and Licenses, net	345,441	342,834
Licensing Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Intangilble assets, gross	207,244	207,244
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Intangilble assets, gross	$ 178,878	$ 166,159

NOTE 6 - ACCRUED EXPENSES (Det

NOTE 6 - ACCRUED EXPENSES (Details) - Schedule of Accrued Liabilities - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Schedule of Accrued Liabilities [Abstract]
Executive compensation	$ 327,285	$ 153,432
Other accruals	27,372	19,725
	$ 354,657	$ 173,157

NOTE 7 - NOTES PAYABLE (Details

NOTE 7 - NOTES PAYABLE (Details) - USD ($)	Mar. 11, 2015	Mar. 25, 2014	Mar. 31, 2015	Sep. 30, 2015	Dec. 31, 2014
NOTE 7 - NOTES PAYABLE (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)				21,548,954	7,271,454
Line of Credit [Member]
NOTE 7 - NOTES PAYABLE (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 60,000
Line of Credit, Current				$ 57,923
Line of Credit [Member] | Prime Rate [Member]
NOTE 7 - NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate		3.00%
Notes Payable, Other Payables [Member]
NOTE 7 - NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Face Amount	$ 50,000
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Debt Instrument, Maturity Date	May 15, 2015
Debt Instrument, Unamortized Discount	$ 3,000
Warrants, Term of Warrants	3 years
Class of Warrant or Rights, Granted (in Shares)	50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.10
Warrants, Fair Value of Warrants, Granted	$ 6,850
Interest Expense, Debt			$ 6,850

NOTE 7 - NOTES PAYABLE (Detai36

NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Notes payable - current
Notes payable	$ 5,488	$ 51,030
Note Payable 1 [Member] | Loans Payable [Member]
Notes payable - current
Notes payable	0	2,304
Note Payable 2 [Member] | Loans Payable [Member]
Notes payable - current
Notes payable	4,268	0
Note Payable 3 [Member] | Loans Payable [Member]
Notes payable - current
Notes payable	1,220	0
Note Payable 4 [Member] | Loans Payable [Member]
Notes payable - current
Notes payable	0	23,726
Note Payable 5 [Member] | Loans Payable [Member]
Notes payable - current
Notes payable	$ 0	$ 25,000

NOTE 7 - NOTES PAYABLE (Detai37

NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants granted (in Shares)			21,548,954		7,271,454
Note, loss on settlement (in Dollars)	$ 0	$ 0	$ 32,500	$ 0
Note Payable 1 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
%	7.85%		7.85%		7.85%
Due monthly (in Dollars)			$ 473		$ 473
Note Payable 2 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
%	5.86%		5.86%
Due monthly (in Dollars)			$ 545
Note Payable 3 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
%	7.85%		7.85%		7.85%
Due monthly (in Dollars)			$ 314		$ 314
Note Payable 4 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
%	4.15%		4.15%		4.15%
Due monthly (in Dollars)			$ 3,436		$ 3,436
Note Payable 5 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
%	10.00%		10.00%		10.00%
Due			Due on demand		Due on demand
Note settled in exchange for common stock (in Shares)			250,000
Warrants granted (in Shares)			500,000
Note, loss on settlement (in Dollars)			$ 32,500
Warrants			3 years
Minimum [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)					$ 0.36
Minimum [Member] | Note Payable 5 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	$ 0.125		$ 0.125
Maximum [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)					$ 10
Maximum [Member] | Note Payable 5 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	$ 0.15		$ 0.15

NOTE 7 - NOTES PAYABLE (Detai38

NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt - USD ($)	Sep. 30, 2015	Dec. 31, 2014
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	$ 118,592	$ 357,646
Convertible Note Payable, Related Party	14,440	9,399
Convertible Note 1 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	48,592	42,254
Convertible Note 2 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	50,000	50,000
Convertible Note 3 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	22,638
Convertible Note 4 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	90,200
Convertible Note 5 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	8,623
Convertible Note 6 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	30,532
Convertible Note 7 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	33,810
Convertible Note 8 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	25,380
Convertible Note 9 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	10,000	8,273
Convertible Note 10 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	10,000	8,195
Convertible Note 11 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	20,488
Convertible Note 12 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	17,253
Related Party Convertible Note 1 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable, Related Party	$ 14,440	$ 9,399

NOTE 7 - NOTES PAYABLE (Detai39

NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants granted (in Shares)	21,548,954	7,271,454
Convertible Note 1 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	8.00%	8.00%
Due on	Dec. 26, 2015	Dec. 26, 2015
Discount related to beneficial conversion feature	$ 1,408	$ 7,746
Convertible at (in Dollars per share)	$ 5	$ 5
Convertible Note 2 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	6.00%	6.00%
Convertible at (in Dollars per share)	$ 2	$ 2
Due	Due on demand	Due on demand
Convertible Note 3 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	March 2,015	March 2,015
Discount related to warrants	$ 0	$ 2,362
Converted to common stock (in Shares)	275,000
Warrants granted (in Shares)	550,000
Warrants	3 years
Convertible Note 4 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	April 2,015	April 2,015
Discount related to warrants	$ 0	$ 9,800
Converted to common stock (in Shares)	1,100,000
Warrants granted (in Shares)	2,200,000
Warrants	3 years
Convertible Note 5 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	April 2,015	April 2,015
Discount related to warrants	$ 0	$ 1,377
Convertible Note 6 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	8.00%	8.00%
Discount related to beneficial conversion feature	$ 0	$ 11,968
Due	April 2,015	April 2,015
Converted to common stock (in Shares)	527,911
Convertible Note 7 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	8.00%	8.00%
Discount related to beneficial conversion feature	$ 0	$ 19,190
Due	May 2,015	May 2,015
Converted to common stock (in Shares)	318,471
Note converted	$ 25,000
Note repaid in cash	$ 28,000
Convertible Note 8 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	December 2,015	December 2,015
Discount related to warrants	$ 0	$ 4,620
Convertible Note 9 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	December 2,015	December 2,015
Discount related to warrants	$ 0	$ 1,727
Convertible Note 10 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	October 2,015	October 2,015
Discount related to warrants	$ 0	$ 1,805
Convertible Note 11 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	October 2,015	October 2,015
Discount related to warrants	$ 0	$ 4,512
Converted to common stock (in Shares)	275,000
Warrants granted (in Shares)	550,000
Warrants	3 years
Convertible Note 12 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	8.00%	8.00%
Discount related to beneficial conversion feature	$ 0	$ 36,247
Due	September 2,015	September 2,015
Related Party Convertible Note 1 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	0.00%	0.00%
Discount related to beneficial conversion feature	$ 274	$ 2,738
Convertible at (in Dollars per share)	$ 0.30	$ 0.30
Due	November 2,015	November 2,015
Discount related to warrants	$ 286	$ 2,863
Minimum [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)		$ 0.36
Minimum [Member] | Convertible Note 3 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	$ 0.125
Minimum [Member] | Convertible Note 4 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	0.125
Minimum [Member] | Convertible Note 11 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	0.125
Maximum [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)		$ 10
Maximum [Member] | Convertible Note 3 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	0.15
Maximum [Member] | Convertible Note 4 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	0.15
Maximum [Member] | Convertible Note 11 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	$ 0.15

NOTE 8 - RELATED PARTY TRANSA40

NOTE 8 - RELATED PARTY TRANSACTIONS (Details) - USD ($)	Apr. 17, 2015	Jul. 01, 2014	Sep. 30, 2014	Sep. 30, 2015	Dec. 31, 2014
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)				21,548,954	7,271,454
Chief Executive Officer [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)	600,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 120,000
Chief Operating Officer [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)	550,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 110,000
Director [Member] | Convertible Debt [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		0.00%
Debt Instrument, Face Amount		$ 15,000
Warrants, Term of Warrants		5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		15,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$ 0.50
Warrants, Fair Value of Warrants, Granted		$ 5,445
Debt Instrument, Convertible, Conversion Price (in Dollars per share)		$ 0.50
Debt Instrument, Convertible, Beneficial Conversion Feature		$ 7,545
Director [Member] | Note Extension [Member] | Convertible Debt [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)			$ 0.20
Warrants, Fair Value of Warrants, Granted			$ 3,435
Debt Instrument, Convertible, Conversion Price (in Dollars per share)			$ 0.30
Debt Instrument, Convertible, Beneficial Conversion Feature			$ 3,285
Class of Warrant or Rights, Granted (in Shares)			15,000
Debt Instrument, Difference in Fair Value Related to Modification			$ 27
Director [Member] | Issuance to Director #1 [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)	200,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 40,000
Director [Member] | Issucance to Director #2 [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)	200,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 40,000

NOTE 9 - STOCKHOLDERS' EQUITY41

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - USD ($)	May. 20, 2015	May. 26, 2011	Sep. 17, 2010	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Preferred Stock, Shares Authorized				5,000,000						5,000,000		5,000,000
Class of Warrant or Rights, Exercised										2,158,867
Gains (Losses) on Restructuring of Debt (in Dollars)				$ 6,906			$ 0	$ 103,021		$ 6,906	$ 103,021
Warrants, Grants in Period, Weighted-Average Grant Date Fair Value (in Dollars per share)										$ 0.14		$ 0.39
2010 Stock Incentive Plan [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			4,650,000
Share-based Compensation Arrangement by Share-based Payment Award, Description			an annual increase in shares of 50,000 as of January 1 of each year; commencing January 1, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant				1,803,530						1,803,530
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)				$ 119,011						$ 119,011
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition										11 years
Stock Issued for Services Rendered [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services				418,750	365,000	28,000	75,000	23,000	64,700
Stock Issued During Period, Value, Issued for Services (in Dollars)				$ 82,838	$ 78,913	$ 10,383	$ 33,713	$ 13,113	$ 39,556
Stock Issued During Period, Shares, Share-based Compensation, Gross					1,550,000
Stock Issued During Period, Value, Share-based Compensation, Gross (in Dollars)					$ 310,000
Conversion of Accounts Payable [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities				193,856	305,165	55,500	7,813	80,000	6,717
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)				$ 22,776	$ 96,732	$ 11,100	$ 5,000	$ 46,400	$ 4,501
Extinguishment of Debt, Amount (in Dollars)								$ 149,421
Covnersion of Convertible Notes Payable and Acrrued Interest [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities				322,500	1,900,000	846,382	645,885	151,126
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)							$ 77,200	$ 32,520
Stock Issued for Cash [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues				567,901	4,350,000	430,000
Stock Issued During Period, Value, New Issues (in Dollars)				$ 40,168	$ 435,000	$ 85,005
Stock Issued for Payment of Accrued Payroll [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities							2,592,570
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)				$ 14,072			$ 777,770
Stock Issued During Period, Shares, Share-based Compensation, Gross				111,683
Conversion of Warrants [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities					2,050,923
Class of Warrant or Rights, Exercised					2,158,867
Conversion of Convertible Note Payable [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities							400,000
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)							$ 107,882
Distributor Agreement [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Other							50,000
Stock Issued During Period, Value, Other (in Dollars)							$ 21,500
Stock Issued for Future Services [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services									79,293
Stock Issued During Period, Value, Issued for Services (in Dollars)									$ 44,250
Options Granted for Non-Employee Services [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Warrants, Term of Warrants	5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.20
Derivative, Gain (Loss) on Derivative, Net (in Dollars)	$ (4,524)
Series A Preferred Stock [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Preferred Stock, Shares Authorized		350,000		350,000						350,000		350,000
Preferred Stock, No Par Value (in Dollars per share)		$ 0.001
Preferred Stock, Conversion Basis		one-for-ten
Conversion of Stock, Shares Converted				1,500	8,000		30,000	44,162
Conversion of Stock, Shares Issued				15,000	80,000		300,000	441,620
Principal [Member] | Covnersion of Convertible Notes Payable and Acrrued Interest [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)				$ 30,000	$ 175,000	67,500	$ 75,500	$ 30,000
Interest [Member] | Covnersion of Convertible Notes Payable and Acrrued Interest [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)				$ 2,250	$ 12,500	$ 1,720	$ 1,700	$ 2,520
Employees [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Warrants, Term of Warrants	5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.40
Derivative, Gain (Loss) on Derivative, Net (in Dollars)	$ (56,543)

NOTE 9 - STOCKHOLDERS' EQUITY42

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Stock Options, Activity - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]
Options Outstanding, Number of Shares (in Shares)	2,866,470		2,352,099
Options Outstanding, Weighted Average Exercise Price	$ 0.48		$ 0.51
Options Outstanding, Weighted Average Remaining Contractual Term	11 years 87 days	8 years 350 days	7 years 328 days
Options Outstanding, Aggregate Intrinsic Value (in Dollars)			$ 199,505
Options Exercisable, Number of Shares (in Shares)	2,321,001		1,810,344
Options Exercisable, Weighted Average Exercise Price	$ 0.47		$ 0.52
Options Exercisable, Weighted Average Remaining Contractual Term	11 years 240 days	9 years 6 months	7 years 321 days
Options Exercisable, Aggregate Intrinsic Value (in Dollars)			$ 138,707
Options Granted, Number of Shares (in Shares)	30,000	624,571
Options Granted, Exercise Price	$ 0.20
Options Granted, Weighted Average Exercise Price	$ 0.20	$ 0.52
Options Granted, Weighted Average Remaining Contractual Term	5 years	6 years 178 days
Options Exercised, Number of Shares (in Shares)	0	0
Options Exercised, Weighted Average Exercise Price	$ 0	$ 0
Options Expired, Number of Shares (in Shares)	0	110,200
Options Expired, Weighted Average Exercise Price	$ 0	$ 0.48
Options Expired, Weighted Average Remaining Contractual Term		9 years 186 days
Options Outstanding, Number of Shares (in Shares)	2,896,470	2,866,470
Options Outstanding, Weighted Average Exercise Price	$ 0.46	$ 0.48
Options Exercisable, Number of Shares (in Shares)	2,652,799	2,321,001
Options Exercisable, Weighted Average Exercise Price	$ 0.45	$ 0.47
Minimum [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]
Options Outstanding, Exercise Price	0.30		$ 0.38
Options Exercisable, Exercise Price	0.38		0.38
Options Granted, Exercise Price		0.40
Options Expired, Exercise Price		0.40
Options Outstanding, Exercise Price	0.20	0.30
Options Exercisable, Exercise Price	0.20	0.38
Maximum [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]
Options Outstanding, Exercise Price	1		1
Options Exercisable, Exercise Price	1		$ 1
Options Granted, Exercise Price		0.75
Options Expired, Exercise Price		0.50
Options Outstanding, Exercise Price	1	1
Options Exercisable, Exercise Price	$ 1	$ 1

NOTE 9 - STOCKHOLDERS' EQUITY43

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range - $ / shares	Sep. 30, 2015	Dec. 31, 2014	Dec. 31, 2012
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	2,896,470	2,866,470	2,352,099
Options Exercisable at $0.20 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	190,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.20
Options Exercisable at $0.30 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	300,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.30
Options Exercisable at $0.38 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	55,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.38
Options Exercisable at $0.40 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	1,186,670
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.40
Options Exercisable at $0.45 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	10,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.45
Options Exercisable at $0.50 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	631,800
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.50
Options Exercisable at $0.60 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	160,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.60
Options Exercisable at $0.62 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	15,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.62
Options Exercisable at $0.75 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	100,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.75
Options Exercisable at $0.81 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	10,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.81
Options Exercisable at $0.85 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	200,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.85
Options Exercisable at $1.00 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	38,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 1

NOTE 9 - STOCKHOLDERS' EQUITY44

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Stockholders' Equity Note, Warrants - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	21,548,954	7,271,454
Warrants Outstanding, Expiration		05/2015 - 10/2024
Less:
Expired (in Shares)	298,509
Exercised (in Shares)	2,158,867
Total (in Shares)	19,091,578
Warrants Issued July 2014 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	1,445,000
Warrants Outstanding, Expiration	07/2018
Warrants Issued June 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	302,500
Warrants Outstanding, Expiration	06/2018
Warrants Issued May 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	6,160,000
Warrants Outstanding, Expiration	05/2018 - 05/2022
Warrants Issued April 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	6,160,000
Warrants Outstanding, Expiration	04/2018 - 04/2027
Warrants Issued March 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	140,000
Warrants Outstanding, Expiration	03/2018 - 03/2022
Warrants Issued February 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	0
Warrants Outstanding, Exercise Price	$ 0
Warrants Issued January 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	70,000
Warrants Outstanding, Expiration	01/2020
Minimum [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price		$ 0.36
Minimum [Member] | Warrants Issued July 2014 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	$ 0.125
Minimum [Member] | Warrants Issued June 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.125
Minimum [Member] | Warrants Issued May 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.125
Minimum [Member] | Warrants Issued April 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.01
Minimum [Member] | Warrants Issued March 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.10
Minimum [Member] | Warrants Issued January 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.30
Maximum [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price		$ 10
Maximum [Member] | Warrants Issued July 2014 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.15
Maximum [Member] | Warrants Issued June 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.15
Maximum [Member] | Warrants Issued May 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.23
Maximum [Member] | Warrants Issued April 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.15
Maximum [Member] | Warrants Issued March 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	0.75
Maximum [Member] | Warrants Issued January 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding, Exercise Price	$ 0.50

NOTE 9 - STOCKHOLDERS' EQUITY45

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Fair Value Measurements, Warrants, Valuation Assumptions - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected dividend yield	0.00%	0.00%
(in Dollars per share)	$ 0.14	$ 0.39
Minimum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk-Free interest rate	0.28%	0.28%
Volatility	166.10%	182.81%
Expected life	3 years	3 years
Maximum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk-Free interest rate	1.72%	2.97%
Volatility	204.66%	222.30%
Expected life	7 years	10 years

NOTE 10 - COMMITMENTS AND CON46

NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) - Land and Building [Member]	May. 08, 2015USD ($)	Apr. 04, 2012USD ($)ft²	Jun. 30, 2014USD ($)	Oct. 31, 2013USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)
NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Area of Real Estate Property (in Square Feet) | ft²		13,081
Operating Leases, Rent Expense, Minimum Rentals		$ 3,160	$ 3,343	$ 3,260
Operating Leases, Rent Expense, Net					$ 0	$ 5,406
Lessee Leasing Arrangements, Operating Leases, Term of Contract	3 years
Operating Lease, Monthly Rental Expense, Year 1 [Member]
NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals	$ 3,343
Operating Lease, Monthly Rental Expense, Year 2 [Member]
NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals	3,410
Operating Lease, Monthly Rental Expense, Year 3 [Member]
NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals	$ 3,478